A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective

02/19/2021
by   Stephen Bonner, et al.
0

Drug discovery and development is an extremely complex process, with high attrition contributing to the costs of delivering new medicines to patients. Recently, various machine learning approaches have been proposed and investigated to help improve the effectiveness and speed of multiple stages of the drug discovery pipeline. Among these techniques, it is especially those using Knowledge Graphs that are proving to have considerable promise across a range of tasks, including drug repurposing, drug toxicity prediction and target gene-disease prioritisation. In such a knowledge graph-based representation of drug discovery domains, crucial elements including genes, diseases and drugs are represented as entities or vertices, whilst relationships or edges between them indicate some level of interaction. For example, an edge between a disease and drug entity might represent a successful clinical trial, or an edge between two drug entities could indicate a potentially harmful interaction. In order to construct high-quality and ultimately informative knowledge graphs however, suitable data and information is of course required. In this review, we detail publicly available primary data sources containing information suitable for use in constructing various drug discovery focused knowledge graphs. We aim to help guide machine learning and knowledge graph practitioners who are interested in applying new techniques to the drug discovery field, but who may be unfamiliar with the relevant data sources. Overall we hope this review will help motivate more machine learning researchers to explore combining knowledge graphs and machine learning to help solve key and emerging questions in the drug discovery domain.

READ FULL TEXT
research
08/30/2021

Demystifying Drug Repurposing Domain Comprehension with Knowledge Graph Embedding

Drug repurposing is more relevant than ever due to drug development's ri...
research
12/13/2021

Implications of Topological Imbalance for Representation Learning on Biomedical Knowledge Graphs

Improving on the standard of care for diseases is predicated on better t...
research
12/18/2020

Biomedical Knowledge Graph Refinement and Completion using Graph Representation Learning and Top-K Similarity Measure

Knowledge Graphs have been one of the fundamental methods for integratin...
research
12/09/2020

Utilising Graph Machine Learning within Drug Discovery and Development

Graph Machine Learning (GML) is receiving growing interest within the ph...
research
05/17/2021

Understanding the Performance of Knowledge Graph Embeddings in Drug Discovery

Knowledge Graphs (KG) and associated Knowledge Graph Embedding (KGE) mod...
research
03/31/2019

Modeling Drug-Disease Relations with Linguistic and Knowledge Graph Constraints

FDA drug labels are rich sources of information about drugs and drug-dis...
research
03/25/2022

Biolink Model: A Universal Schema for Knowledge Graphs in Clinical, Biomedical, and Translational Science

Within clinical, biomedical, and translational science, an increasing nu...

Please sign up or login with your details

Forgot password? Click here to reset